JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2226
CALL
Aflac
AFL
$56.2B
| $15.5M | ﹤0.01% |
150,200
-14,500
| -9% | -$1.58M |
2022 Q4
8 quarters
|
|
|
OPTU
2227
Optimum Communications Inc
OPTU
$372M
| $15.5M | ﹤0.01% |
6,444,193
+4,541,359
| +239% | +$11.3M |
2017 Q2
30 quarters
|
|
2228
CALL
American Airlines Group
AAL
$8.53B
| $15.5M | ﹤0.01% |
890,800
-20,400
| -2% | -$293K |
2022 Q4
8 quarters
|
|
2229
PUT
Yum China
YUMC
$13.6B
| $15.5M | ﹤0.01% |
322,300
| – | – |
2023 Q2
6 quarters
|
|
2230
Invesco S&P 500 Quality ETF
SPHQ
$18.9B
| $15.5M | ﹤0.01% |
231,427
+11,909
| +5% | +$807K |
2022 Q1
11 quarters
|
|
2231
Bio-Rad Laboratories Class A
BIO
$10.1B
| $15.5M | ﹤0.01% |
47,148
-6,988
| -13% | -$2.37M |
2013 Q2
46 quarters
|
|
2232
JPMorgan US Momentum Factor ETF
JMOM
$2.82B
| $15.5M | ﹤0.01% |
265,709
+171,043
| +181% | +$10.1M |
2017 Q4
28 quarters
|
|
2233
PUT
Target
TGT
$69.7B
| $15.5M | ﹤0.01% |
114,500
-156,000
| -58% | -$22.4M |
2021 Q3
13 quarters
|
|
2234
PUT
Constellation Brands
STZ
$19.4B
| $15.5M | ﹤0.01% |
70,000
| – | – |
2021 Q3
13 quarters
|
|
2235
Byline Bancorp
BY
$1.7B
| $15.5M | ﹤0.01% |
533,292
-23,950
| -4% | -$694K |
2017 Q4
28 quarters
|
|
2236
PUT
Take-Two Interactive
TTWO
$37.9B
| $15.5M | ﹤0.01% |
84,000
+12,400
| +17% | +$2.15M |
2021 Q1
15 quarters
|
|
2237
Oshkosh
OSK
$8.36B
| $15.4M | ﹤0.01% |
162,405
-33,501
| -17% | -$3.51M |
2013 Q2
46 quarters
|
|
2238
PUT
Nike
NKE
$50.2B
| $15.4M | ﹤0.01% |
204,000
+29,300
| +17% | +$2.3M |
2016 Q1
35 quarters
|
|
2239
Asana
ASAN
$2.04B
| $15.4M | ﹤0.01% |
761,221
-71,377
| -9% | -$1.13M |
2020 Q3
17 quarters
|
|
2240
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.2B
| $15.4M | ﹤0.01% |
215,429
+35,391
| +20% | +$2.55M |
2022 Q4
8 quarters
|
|
2241
CALL
CF Industries
CF
$17.8B
| $15.4M | ﹤0.01% |
180,300
-94,900
| -34% | -$8.21M |
2023 Q4
4 quarters
|
|
2242
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$6.28B
| $15.4M | ﹤0.01% |
410,752
-75,820
| -16% | -$2.89M |
2018 Q3
25 quarters
|
|
|
CPRX
2243
DELISTED
Catalyst Pharmaceutical
CPRX
| $15.4M | ﹤0.01% |
736,197
+327,936
| +80% | +$7.05M |
2017 Q1
31 quarters
|
|
|
FOPC
2244
Frontier Asset Opportunistic Credit ETF
FOPC
$31.8M
| $15.4M | ﹤0.01% |
+612,514
| New | +$15.3M |
2024 Q4
0 quarters
|
|
2245
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.47B
| $15.3M | ﹤0.01% |
307,096
-1,085,070
| -78% | -$54.4M |
2020 Q1
19 quarters
|
|
2246
CALL
The Kraft Heinz Company
KHC
$26B
| $15.3M | ﹤0.01% |
498,300
+1,200
| +0.2% | +$39.3K |
2020 Q2
18 quarters
|
|
2247
CALL
NXP Semiconductors
NXPI
$61B
| $15.3M | ﹤0.01% |
73,600
-8,000
| -10% | -$1.82M |
2023 Q2
6 quarters
|
|
2248
Grupo Cibest SA
CIB
$22.8B
| $15.3M | ﹤0.01% |
484,281
+138,461
| +40% | +$4.46M |
2021 Q2
14 quarters
|
|
2249
Atlantic Union Bankshares
AUB
$5.51B
| $15.2M | ﹤0.01% |
402,247
+311,290
| +342% | +$12.3M |
2013 Q2
46 quarters
|
|
2250
PUT
EOG Resources
EOG
$76.1B
| $15.2M | ﹤0.01% |
123,900
-2,000
| -2% | -$256K |
2022 Q2
10 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.